Financial statements Podopharm

Balance sheet of Podopharm

Company age:
Age:
11 y. 8 m. 12 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of PODOPHARM

Year
2018
2019
2020
2021
2022
2023
Total assets 1 211 219,04 2 201 287,38 2 132 619,88 1 824 779,35 2 303 975,45 2 087 675,91
A. Fixed assets 51 495,84 1 129 744,95 1 181 222,42 1 140 569,98 1 174 000,54 1 042 705,40
B. Current assets 1 159 723,20 1 071 542,43 951 397,46 684 209,37 1 129 974,91 1 044 970,51
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 1 211 219,04 2 201 287,38 2 132 619,88 1 824 779,35 2 303 975,45 2 087 675,91
A. Equity 1 160 351,02 2 192 194,73 2 068 074,90 1 813 800,50 2 444 522,39 2 067 698,81
B. Liabilities and provisions for liabilities 50 868,02 9 092,65 64 544,98 10 978,85 59 453,06 19 977,10
I. Long-term liabilities - - - - - -
II. Short-term liabilities - - - - - 19 977,10
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.